Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Kauko Saarilahti"'
Autor:
Henna Kavaluus, Katri Nousiainen, Sampsa Kaijaluoto, Tiina Seppälä, Kauko Saarilahti, Mikko Tenhunen
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 17, Iss , Pp 58-64 (2021)
Background and Purpose: Magnetic resonance imaging is increasingly used in radiotherapy planning; yet, the performance of the utilized scanners is rarely regulated by any authority. The aim of this study was to determine the geometric accuracy of sev
Externí odkaz:
https://doaj.org/article/8fdf09a494bb418183acb32d8fdf0ab6
Autor:
Aini Hyytiäinen, Wafa Wahbi, Otto Väyrynen, Kauko Saarilahti, Peeter Karihtala, Tuula Salo, Ahmed Al-Samadi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundHead and neck squamous cell carcinoma (HNSCC) carries poor survival outcomes despite recent progress in cancer treatment in general. Angiogenesis is crucial for tumour survival and progression. Therefore, several agents targeting the pathwa
Externí odkaz:
https://doaj.org/article/c1971bb293a9400683e8975ca00ce588
Publikováno v:
Frontiers in Nutrition, Vol 6 (2019)
Background: Locally advanced head and neck cancer is managed either by combined surgery and (chemo) radiotherapy or definitive (chemo) radiotherapy, which may deteriorate nutritional status. Previous data have shown that intensive nutritional interve
Externí odkaz:
https://doaj.org/article/c82e4e97e59246ca83d52886bd3cd572
Autor:
Leena Voutilainen, Petri Koivunen, Tero Vahlberg, Reidar Grénman, Miia Ruuskanen, Merja Korpela, Antti Mäkitie, Tuija Wigren, Heikki Minn, Kauko Saarilahti, Heikki Irjala, Ilmo Leivo
Publikováno v:
Acta Oncologica. 57:251-256
Nasopharyngeal carcinoma (NPC) is uncommon in western countries and data on the outcome and histological presentation are scarce in nonendemic areas. We report here the outcome on all patients with NPC treated in Finland between 1990 and 2009.The Fin
Autor:
Paula Ravasco, Antti Mäkitie, Kauko Saarilahti, Outi Mäkitie, Pia Österlund, Ursula Schwab, Helena Orell-Kotikangas
Publikováno v:
Acta Oto-Laryngologica. 137:778-785
One third of the patients had cachexia with an association of significantly shorter survival. These results suggest that combining HGS and MAMA seems to be a practical method to screen cachexia in patients with head and neck cancer and may also be us
Autor:
Tom Böhling, Antti Mäkitie, Karri Mesimäki, Risto Kontio, Paula Lindholm, Peppi Koivunen, Mika Sampo, Kauko Saarilahti, Jaana Hagström
Background: Osteosarcomas (OS) in the craniomaxillofacial (CMF) region are typically diagnosed at later age than long-bone OS, but they are reported to have better 5-year survival. Curative treatment warrants wide surgical resection, which is often n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30fe3544f3bcc487b1c23e2a7376aeab
http://urn.fi/urn:nbn:fi-fe2019070322657
http://urn.fi/urn:nbn:fi-fe2019070322657
Publikováno v:
Clinical Medicine Insights: Ear, Nose and Throat, Vol 2016, Iss 9, Pp 1-6 (2016)
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 273:2509-2514
Head and neck cancer patients treated with high-dose cisplatin and radiotherapy will suffer from hearing deficits. The current low-dose regimen seldom causes hearing threshold decrease. Tinnitus in this patient population has not been investigated ea
Autor:
Timo Carpén, Antti Mäkitie, Kauko Saarilahti, Petri S. Mattila, Jussi Tarkkanen, Antti Markkola, Jaana Hagström, Caj Haglund
To investigate the impact of primary gross tumor volume (pGTV) and nodal gross tumor volume (nGTV) in oropharyngeal squamous cell carcinoma (OPSCC) and the difference in their role between human papillomavirus (HPV)-positive and HPV-negative patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de0920d8b0e0fc1c1a689678dbdf5df7
http://hdl.handle.net/10138/304166
http://hdl.handle.net/10138/304166
Autor:
Lauri Koivula, Mika Kapanen, Juhani Collan, Tiina Seppälä, Harri Visapää, Juha Korhonen, Mikko Tenhunen, Kauko Saarilahti
Publikováno v:
Acta oncologica (Stockholm, Sweden). 57(7)
Magnetic resonance imaging (MRI) is the most comprehensive imaging modality for radiation therapy (RT) target delineation of most soft tissue tumors including prostate cancer. We have earlier presented step by step the MRI-only based workflow for RT